This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2024 Jan 27;403(10424):327-330.

doi: 10.1016/S0140-6736(24)00048-5. Epub 2024 Jan 12.

Dihydroartemisinin-piperaquine for prevention of malaria in pregnant women living with HIV

Moses R Kamya¹, Abel Kakuru², Grant Dorsey³

Affiliations

Affiliations

¹ Department of Medicine, Makerere University, PO Box 7072, Kampala, Uganda; Infectious Diseases Research Collaboration, Kampala, Uganda. Electronic address: mkamya@idrc-uganda.org.
² Infectious Diseases Research Collaboration, Kampala, Uganda; Department of Community and Public Health, Busitema University, Tororo, Uganda.
³ and Department of Medicine, University of California, San Francisco, CA, USA.

PMID: 38224711
DOI: 10.1016/S0140-6736(24)00048-5

Comment

Dihydroartemisinin-piperaquine for prevention of malaria in pregnant women living with HIV

Moses R Kamya et al. Lancet. 2024.

. 2024 Jan 27;403(10424):327-330.

doi: 10.1016/S0140-6736(24)00048-5. Epub 2024 Jan 12.

Authors

Moses R Kamya¹, Abel Kakuru², Grant Dorsey³

Affiliations

¹ Department of Medicine, Makerere University, PO Box 7072, Kampala, Uganda; Infectious Diseases Research Collaboration, Kampala, Uganda. Electronic address: mkamya@idrc-uganda.org.
² Infectious Diseases Research Collaboration, Kampala, Uganda; Department of Community and Public Health, Busitema University, Tororo, Uganda.
³ and Department of Medicine, University of California, San Francisco, CA, USA.

PMID: 38224711
DOI: 10.1016/S0140-6736(24)00048-5

No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment on

Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial.
Barsosio HC, Madanitsa M, Ondieki ED, Dodd J, Onyango ED, Otieno K, Wang D, Hill J, Mwapasa V, Phiri KS, Maleta K, Taegtmeyer M, Kariuki S, Schmiegelow C, Gutman JR, Ter Kuile FO. Barsosio HC, et al. Lancet. 2024 Jan 27;403(10424):365-378. doi: 10.1016/S0140-6736(23)02631-4. Epub 2024 Jan 12. Lancet. 2024. PMID: 38224710 Free PMC article. Clinical Trial.

Similar articles

Effect of dihydroartemisinin/piperaquine for malaria intermittent preventive treatment on dolutegravir exposure in pregnant women living with HIV.
Banda CG, Nkosi D, Allen E, Workman L, Madanitsa M, Chirwa M, Kapulula M, Muyaya S, Munharo S, Wiesner L, Phiri KS, Mwapasa V, Ter Kuile FO, Maartens G, Barnes KI. Banda CG, et al. J Antimicrob Chemother. 2022 May 29;77(6):1733-1737. doi: 10.1093/jac/dkac081. J Antimicrob Chemother. 2022. PMID: 35288747 Free PMC article. Clinical Trial.
Safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial.
González R, Nhampossa T, Mombo-Ngoma G, Mischlinger J, Esen M, Tchouatieu AM, Mendes A, Figueroa-Romero A, Zoleko-Manego R, Lell B, Lagler H, Stoeger L, Dimessa LB, El Gaaloul M, Sanz S, Méndez S, Piqueras M, Sevene E, Ramharter M, Saúte F, Menendez C; MAMAH study group. González R, et al. Lancet Infect Dis. 2024 May;24(5):476-487. doi: 10.1016/S1473-3099(23)00738-7. Epub 2024 Jan 12. Lancet Infect Dis. 2024. PMID: 38224706 Clinical Trial.
Dihydroartemisinin-piperaquine treatment failure of uncomplicated Plasmodium falciparum malaria infection in a traveller.
Delandre O, Cassir NS, Taudon N, Mosnier J, Fonta I, Benoit N, Amalvict R, Linard C, Jumpertz M, L'Ollivier C, Bogreau H, Pradines B, Javelle E. Delandre O, et al. J Travel Med. 2024 Apr 6;31(3):taae043. doi: 10.1093/jtm/taae043. J Travel Med. 2024. PMID: 38457636 No abstract available.
Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malaria.
Keating GM. Keating GM. Drugs. 2012 May 7;72(7):937-61. doi: 10.2165/11203910-000000000-00000. Drugs. 2012. PMID: 22515619 Review.
Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis.
Marwa K, Kapesa A, Baraka V, Konje E, Kidenya B, Mukonzo J, Kamugisha E, Swedberg G. Marwa K, et al. PLoS One. 2022 Mar 10;17(3):e0264339. doi: 10.1371/journal.pone.0264339. eCollection 2022. PLoS One. 2022. PMID: 35271592 Free PMC article.

See all similar articles

Cited by

Evolution of Pfdhps and Pfdhfr mutations before and after adopting seasonal malaria chemoprevention in Nanoro, Burkina Faso.
Bohissou FET, Sondo P, Inoue J, Rouamba T, Kaboré B, Nassa GJW, Kambou AES, Traoré TE, Asua V, Borrmann S, Tinto H, Held J. Bohissou FET, et al. Sci Rep. 2024 Oct 16;14(1):24224. doi: 10.1038/s41598-024-75369-2. Sci Rep. 2024. PMID: 39414909 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

U01 AI141308/AI/NIAID NIH HHS/United States

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information